Skip to content

BioLife Solutions BLFS Intangible Purchases

Intangible Purchases at other companies

CryoPort, Inc. logo
CryoPort, Inc.CYRX
$301K-15.2%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: BioLife Solutions’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's intangible purchases?
BioLife Solutions (BLFS) reported intangible purchases of $0 in Q4 2025.
How has BioLife Solutions's intangible purchases changed year-over-year?
BioLife Solutions's intangible purchases decreased by 100.0% year-over-year, from $75K to $0.
What does intangible purchases mean?
Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.